Akash test for clone

Test article to check the clone issue

Test article to check the clone issue

Scrip Podcast

Keep up with the top pharma business news of the week. On the go.

Scrip brings you a weekly bulletin of top picks.

More from Scrip

Sponsored by :

Clinical Trial Complexity Is Reshaping Evidence Collection Clinical trial innovation has historical - Clone

As clinical trials grow more complex, execution pressures are changing where and how evidence is collected.

Easy Access To GLP-1s Is Causing Big Problems For Obesity Studies

in the expanding and competitive field of obesity therapy clinical trials, one trend is increasingly causing a headache: placebo-arm participants dropping out or using “off-protocol” weight-loss treatments while on trial.

More from Financing

Finance Watch: More Than $4.2bn Raised Across Four New VC Funds

 
• By 

Private Company Edition: ARCH raised more than $3bn for its eighth fund, Frazier added $630m to its public fund that also can back crossover rounds, DCVC’s third biotech fund totaled $400m and Asabys raised €180m ($200m) for its second fund. Also, Aktis closed a $175m series B round.

Pentixapharm Poised To Make A Splash In The Radiopharmaceuticals Pool

 
• By 

The German group is spinning off from Eckert & Ziegler and listing in Frankfurt, though a leap to the NASDAQ will likely follow once it has more data on a lymphoma theranostic.

MBX, Zenas And Bicara IPOs Generate Big First Day Returns, But Will They Last?

 
• By 

MBX, Zenas and Bicara delivered positive returns in their first days of trading, but that has not always translated to good long-term results for drug developers that launched US IPOs this year.